These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2562356)

  • 1. Specific immunity to HIV and other retroviral infections.
    Gorny MK; Pinter A; Zolla-Pazner S
    Prog AIDS Pathol; 1989; 1():181-99. PubMed ID: 2562356
    [No Abstract]   [Full Text] [Related]  

  • 2. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells.
    Hinkula J; Walther-Jallow L; Laurén A; Mäkitalo B; Oberg M; Wahren B; Fenyö EM; Spetz AL
    Vaccine; 2009 Oct; 27(46):6424-31. PubMed ID: 19549607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunity and drug addiction: immunologic situation in relation to the drug, HTLV-III infection and other associated infections].
    Asensi V; Cartón JA; Fernández-León A; Cárcaba V; Navia-Osorio JM; Pérez R; Diéguez MA; Arribas JM
    Med Clin (Barc); 1986 Jan; 86(3):105-9. PubMed ID: 3007879
    [No Abstract]   [Full Text] [Related]  

  • 5. Neonate-primed CD8+ memory cells rival adult-primed memory cells in antigen-driven expansion and anti-viral protection.
    Fadel SA; Cowell LG; Cao S; Ozaki DA; Kepler TB; Steeber DA; Sarzotti M
    Int Immunol; 2006 Feb; 18(2):249-57. PubMed ID: 16418189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of cytokines in viral infections].
    Cavallo R; Cavallo F; Cavallo G
    G Batteriol Virol Immunol; 1994; 86(1-12):65-78. PubMed ID: 8706977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune response to HIV: implications for vaccine development.
    Bolognesi DP
    Semin Immunol; 1993 Jun; 5(3):203-14. PubMed ID: 8347841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV. Escape artist par excellence.
    Cohen J
    Science; 2003 Mar; 299(5612):1505-8. PubMed ID: 12624245
    [No Abstract]   [Full Text] [Related]  

  • 9. Retrovirus infections of the nervous system.
    Bangham CR
    Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):176-81. PubMed ID: 8386955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV/AIDS research. Potent HIV antibodies spark vaccine hopes.
    Cohen J
    Science; 2009 Sep; 325(5945):1195. PubMed ID: 19729632
    [No Abstract]   [Full Text] [Related]  

  • 11. Why vaccines are not the answer - the failure of V520 and the importance of cell-mediated immunity in the fight against HIV.
    White A
    Med Hypotheses; 2008 Dec; 71(6):909-13. PubMed ID: 18768264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of polymorphonuclear leukocytes in infection by retroviruses with emphasis on the human immunodeficiency virus.
    Mertins SD; Ortona L; Cauda R
    Viral Immunol; 1990; 3(3):173-94. PubMed ID: 2175193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing HIV. Part 3: Mechanisms of disease. 3.3 How HIV leads to opportunistic infections.
    Crowe SM; Kornbluth RS
    Med J Aust; 1996 Feb; 164(3):171-3. PubMed ID: 8628138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccines for immunodeficiency viruses.
    Robinson HL
    AIDS; 1997; 11 Suppl A():S109-19. PubMed ID: 9451974
    [No Abstract]   [Full Text] [Related]  

  • 15. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
    Emini EA; Koff WC
    Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
    Rollman E; Mathy N; Bråve A; Boberg A; Kjerrström A; van Wely C; Engström G; Johansson S; Aperia K; Eriksson LE; Benthin R; Ertl P; Heeney J; Hinkula J; Voss G; Wahren B
    Vaccine; 2007 Mar; 25(11):2145-54. PubMed ID: 17254672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus.
    Spear GT; Takefman DM; Sullivan BL; Landay AL; Jennings MB; Carlson JR
    Virology; 1993 Aug; 195(2):475-80. PubMed ID: 8337824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies.
    Jaspan HB; Robinson JE; Amedee AM; Van Dyke RB; Garry RF
    J Clin Virol; 2004 Nov; 31(3):190-7. PubMed ID: 15465411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitation of and neutralizing antibodies to AIDS-retroviruses; a novel system using HTLV-I carrying MT-4 cells].
    Harada S; Yamamoto N
    Tanpakushitsu Kakusan Koso; 1985 Dec; 30(13):1394-407. PubMed ID: 3003812
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of HIV and SIV neutralization sensitivity by DC-SIGN and mannose-binding lectin.
    Marzi A; Mitchell DA; Chaipan C; Fisch T; Doms RW; Carrington M; Desrosiers RC; Pöhlmann S
    Virology; 2007 Nov; 368(2):322-30. PubMed ID: 17659761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.